Injective (INJ) is facing renewed resistance after a brief recovery, as market analysts highlight growing bearish momentum across both USDT and BTC trading pairs. Despite short-term rallies, technical indicators suggest the token may be poised for a pullback, while the ecosystem’s ongoing Community BuyBack program continues to influence long-term supply dynamics…
Read More
About The Author
